Angelini pharma investe 115 milioni negli Usa su una molecola per curare l’epilessia
Accordo di collaborazione con Grin therapeutics sulla fase 3 di sviluppo del radiprodil
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.